Clinical Trials in Italy / NCT06717841
Active, not recruiting Observational

Metabolic Control and Glycemic Variability in Type 1 Diabetes and Celiac Disease

NCT06717841 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2020-10-09
Last updated
2024-12-05

Condition(s) studied

Type 1 Diabetes MellitisCeliac Disease

Study summary

This is an observational, retrospective study focused on differences of time-in-range and glycemic variability between a cohort of patients with both type 1 diabetes and celiac disease, and a cohort of patients with only type 1 diabetes.

Eligibility

Sex
ALL
Min age
—
Max age
17 Years
Healthy volunteers
No
Inclusion Criteria: * patients \< 18 years of age at enrollment; * patients with type 1 diabetes onset since at least 1 year and celiac disease (COHORT A); * patients only with type 1 diabetes onset since at least 1 year (COHORT B); * using the continuous glycemic monitoring sensor; * being on treatment with continuous subcutaneous insulin infusion or multidaily injections; * obtaining informed consent from parents/legal guardian of pediatric patients. Exclusion Criteria: * patients with diabetes other than type1 diabetes; * patients not using the glycemic monitoring sensor.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna Italy

More IRCCS Azienda Ospedaliero-Universitaria di Bologna trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06717841 on ClinicalTrials.gov ↗ ← All trials in Italy